Vasoactive agents for the treatment of sepsis

26Citations
Citations of this article
86Readers
Mendeley users who have this article in their library.

Abstract

The article describes some commonly used vasoactive agents in patients with septic shock. Depending on their distinct pharmacological properties, their effects on vascular bed and cardiac function are different. For example, dopamine has equivalent effect on heart and vasculature, which can result in increases in cardiac output, mean arterial pressure and heart rate. Dobutamine is considered as inodilator because it has potent effect on cardiac systole and vasculature. Patients with sepsis and septic shock sometimes have coexisting cardiac dysfunction that justifies the use of dobutamine. Levosimendan is a relatively new agent exerting its inodilator effect by increasing sensitivity of myocardium to calcium. Some preliminary studies showed a promising result of levosimendan on reducing mortality.

Cite

CITATION STYLE

APA

Zhang, Z., & Chen, K. (2016, September 1). Vasoactive agents for the treatment of sepsis. Annals of Translational Medicine. AME Publishing Company. https://doi.org/10.21037/atm.2016.08.58

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free